Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer

Radiation Oncology · Published 2026-07-31 · DOI 10.1186/s13014-026-02902-0

Free full text

Authors (6)

Lanshan Li, Yuling Hong, Zhenyu Lin, Jianping Zhang, Benhua Xu, Zihan Zhou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, L., Hong, Y., Lin, Z., et al. (2026). Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer. Radiation Oncology. https://doi.org/10.1186/s13014-026-02902-0

Related articles